Biomx Inc (PHGE)

Sector:
FINANCE
Industry:
GENERAL FINANCE
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Jonathan E. Solomon
Employees:
120
17 STATE STREET, 16TH FLOOR, NEW YORK, NY 10004
646-465-9000

BiomX Inc. develops products using natural and engineered phage technologies to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC) The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S.Aureus), a bacteria associated

Data derived from most recent annual or quarterly report
Market Cap 11.863 Million Shares Outstanding45.98 Million Avg 30-day Volume 260.249 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.23
Price to Revenue0.0 Debt to Equity0.8953 EBITDA-24.269 Million
Price to Book Value1.0433 Operating Margin0.0 Enterprise Value94.703 Thousand
Current Ratio EPS Growth0 Quick Ratio
1 Yr BETA 0.3737 52-week High/Low 0.69 / 0.13 Profit Margin0.0
Operating Cash Flow Growth30.2863 Free Cash Flow to Firm (FCFF) TTM 1.931 Million Free Cash Flow to Equity (FCFE) TTM-17.813 Million
Altman Z-Score

Are you looking for this stock instead?

View SEC Filings from PHGE instead.

View recent insider trading info

Biomx Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding PHGE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PHGE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

10.9 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ORON ASSAF CHIEF BUSINESS OFFICER

  • Officer
 0 2023-11-29 5

SOLOMON JONATHAN EITAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2023-10-29 2

BASSAN MERAV CHIEF DEVELOPMENT OFFICER

  • Officer
 0 2023-10-29 2

WOLFSON MARINA CHIEF FINANCIAL OFFICER

  • Officer
 0 2023-10-29 2

WILLIAMS EDDIE

  • Director
 0 2023-10-19 2

MARKS JASON M.

  • Director
 0 2023-08-21 2

DAMBACH MICHAEL E.

  • Director
 0 2023-08-21 2

SULLIVAN LYNNE MARIE

  • Director
 0 2023-03-01 1

GREIG RUSSELL

  • Director
 0 2023-03-01 1

MOSES ALAN CHARLES

  • Director
 0 2023-03-01 1

ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP

ORBIMED ISRAEL GP LTD.

GORDON CARL L

CHIMOVITS EREZ

  • 10% Owner
 3,161,489 2023-02-27 1

UGWUMBA CHIDOZIE

  • EXIT FORM 4 - FORMER 10% OWNER
 2,997,025 2022-10-17 0

GROSSMAN JONAS

  • Director
 20,500 2022-03-29 0

AMUSA GBOLAHAN

  • Director
 20,500 2022-03-29 0

WALTON THOMAS LAYTON

  • 10% Owner
 0 2021-12-31 0

SEKHRI PAUL J

  • Director
 21,875 2021-07-28 0

ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP

ORBIMED ISRAEL GP LTD.

  • 10% Owner
 2,813,489 2021-07-28 0

PUTTAGUNTA SAILAJA CHIEF MEDICAL OFFICER

  • Officer
 71,250 2021-03-30 0

CHIMOVITS EREZ

  • Director
  • 10% Owner
 2,313,489 2020-03-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ORON ASSAF - Officer CHIEF BUSINESS OFFICER

2023-12-01 16:46:56 -0500 2023-11-29 S 5,444 $0.40 d 5,470 direct

ORON ASSAF - Officer CHIEF BUSINESS OFFICER

2023-12-01 16:46:56 -0500 2023-11-29 S 3,414 $0.35 d 2,056 direct

ORON ASSAF - Officer CHIEF BUSINESS OFFICER

2023-12-01 16:46:56 -0500 2023-11-29 S 2,056 $0.34 d 0 direct

SOLOMON JONATHAN EITAN - Director - Officer CHIEF EXECUTIVE OFFICER

2023-10-31 17:09:50 -0400 2023-10-29 A 201,708 a 0 direct

BASSAN MERAV - Officer CHIEF DEVELOPMENT OFFICER

2023-10-31 17:13:55 -0400 2023-10-29 D 189,997 d 0 direct

BASSAN MERAV - Officer CHIEF DEVELOPMENT OFFICER

2023-10-31 17:13:55 -0400 2023-10-29 A 189,997 a 0 direct

WOLFSON MARINA - Officer CHIEF FINANCIAL OFFICER

2023-10-31 17:10:52 -0400 2023-10-29 A 59,800 a 59,800 direct

SOLOMON JONATHAN EITAN - Director - Officer CHIEF EXECUTIVE OFFICER

2023-10-31 17:09:50 -0400 2023-10-29 D 284,701 d 0 direct

SOLOMON JONATHAN EITAN - Director - Officer CHIEF EXECUTIVE OFFICER

2023-10-31 17:09:50 -0400 2023-10-29 A 284,701 a 0 direct

SOLOMON JONATHAN EITAN - Director - Officer CHIEF EXECUTIVE OFFICER

2023-10-31 17:09:50 -0400 2023-10-29 D 201,708 d 0 direct

SOLOMON JONATHAN EITAN - Director - Officer CHIEF EXECUTIVE OFFICER

2023-10-31 17:09:50 -0400 2023-10-29 D 182,133 d 0 direct

SOLOMON JONATHAN EITAN - Director - Officer CHIEF EXECUTIVE OFFICER

2023-10-31 17:09:50 -0400 2023-10-29 A 182,133 a 0 direct

ORON ASSAF - Officer CHIEF BUSINESS OFFICER

2023-10-31 17:08:29 -0400 2023-10-29 D 155,363 d 0 direct

ORON ASSAF - Officer CHIEF BUSINESS OFFICER

2023-10-31 17:08:29 -0400 2023-10-29 A 155,363 a 0 direct

ORON ASSAF - Officer CHIEF BUSINESS OFFICER

2023-10-31 17:08:29 -0400 2023-10-29 D 82,667 d 0 direct

ORON ASSAF - Officer CHIEF BUSINESS OFFICER

2023-10-31 17:08:29 -0400 2023-10-29 A 82,667 a 0 direct

ORON ASSAF - Officer CHIEF BUSINESS OFFICER

2023-10-31 17:08:29 -0400 2023-10-29 D 46,966 d 0 direct

ORON ASSAF - Officer CHIEF BUSINESS OFFICER

2023-10-31 17:08:29 -0400 2023-10-29 A 46,966 a 0 direct

WILLIAMS EDDIE - Director

2023-10-23 16:26:34 -0400 2023-10-19 A 41,000 a 41,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOMX INC PHGE 2023-12-01 22:15:04 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 21:45:05 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 21:15:04 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 20:45:04 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 20:15:04 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 19:45:04 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 19:15:04 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 18:45:05 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 18:15:03 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 17:45:04 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 17:15:03 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 16:45:03 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 16:15:04 UTC -70.9362 76.2562 400000
BIOMX INC PHGE 2023-12-01 15:45:03 UTC -70.9362 76.2562 500000
BIOMX INC PHGE 2023-12-01 15:15:05 UTC -70.9362 76.2562 500000
BIOMX INC PHGE 2023-12-01 14:45:03 UTC -70.9362 76.2562 500000
BIOMX INC PHGE 2023-12-01 14:15:04 UTC -70.9362 76.2562 500000
BIOMX INC PHGE 2023-12-01 13:45:04 UTC -67.0232 72.3432 500000
BIOMX INC PHGE 2023-12-01 13:15:04 UTC -67.0232 72.3432 300000
BIOMX INC PHGE 2023-12-01 12:45:04 UTC -67.0232 72.3432 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments